Rituxan
Links shared publicly online about this topic
"Son of Rituxan" in Peril - Pathophilia
bmartinmd.com — “"Son of Rituxan" in Peril - Pathophilia” View full resource at bmartinmd.com
Most Recently Shared on March 8, 2010 at 6:18 pm By:
Barbara J. Martin Doctor, Neurologist, and Physician
"Son of Rituxan" in Peril: Trials of the monoclonal antibody ocrelizumab, a humanized version of the uber-mAb ritu... http://bit.ly/dygMzE
Rituxan approved for chronic lymphocytic leukemia - MPR
empr.com — “The FDA has approved Rituxan (rituximab, from Genentech) in combination with fludarabine and cyclophosphamide (FC) for patients with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).” View full resource at empr.com
Most Recently Shared on February 19, 2010 at 3:50 pm By:
MPR News: Rituxan approved for chronic lymphocytic leukemia: The FDA has approved Rituxan (rituximab, from Genente... http://bit.ly/deIPpG
Brass and Ivory: Rituxan
brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\” View full resource at brassandivory.blogspot.com
Most Recently Shared on January 6, 2010 at 5:00 pm By:
@BUBYSGIRL I've started using Rituxan. Info for MS - http://bit.ly/807oPl More info on my experience linked here - http://bit.ly/90pn6d
FDA Alert: Rituxan (rituximab) - PML
drugs.com — “FDA Alert: Rituxan (rituximab) - PML” View full resource at drugs.com
Most Recently Shared on October 24, 2009 at 3:51 am By:
FDA Alert - Rituxan (rituximab) - Third Case of PML Reported - http://bit.ly/2blHZY
FDA Alert: Rituxan (rituximab) - PML
drugs.com — “FDA Alert: Rituxan (rituximab) - PML” View full resource at drugs.com
Most Recently Shared on October 24, 2009 at 2:10 pm By:
RT @drugscom FDA Alert: Rituxan (rituximab) - PML http://bit.ly/2QIfwP
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
drugs.com — “Rituxan (rituximab) is used to treat Chronic Lymphocytic Leukemia. Includes Rituxan side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 22, 2010 at 11:41 pm By:
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia - http://bit.ly/960vQR
RITUXAN (Rituximab) drug information from MPR
empr.com — “RITUXAN (Rituximab) drug information for Microscopic polyangitis, Wegener's granulomatosis from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on July 21, 2011 at 6:02 am By:
MPR News: RITUXAN: Indications: approved for Wegener's granulomatosis and microscopic polyangiitis. http://bit.ly/mUJVDj
Biogen's Rituxan Label Expansion Delayed
zacks.com — “Biogen's rituxan label expansion delayed-biogen works towards gaining final approval for the expanded indication and are planning to continue final label discussions with the fda” View full resource at zacks.com
Most Recently Shared on November 20, 2009 at 5:09 pm By:
Rituxan shot down as part of first-line therapy for CLL http://bit.ly/8LKlRa
Rituxan Approved for Chronic Lymphocytic Leukemia - Yahoo! News
news.yahoo.com — “FRIDAY, Feb. 19 (HealthDay News) -- Rituxan (rituximab) has been approved by the U.S. Food and Drug Administration to treat a slowly progressing form of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL), the agency said in a press release.” View full resource at news.yahoo.com
Most Recently Shared on February 22, 2010 at 7:15 pm By:
Hisham Rana, MD Doctor and Physician
News: Rituxan (rituximab) Approved for Chronic Lymphocytic Leukemia http://bit.ly/bR6GuM - #cancer #health #pharma #medicine
Treatment With Rituxan May Reduce Recurrence of Follicular Lymphoma:
health.msn.com — “Treatment With Rituxan May Reduce Recurrence of Follicular Lymphoma:” View full resource at health.msn.com
Most Recently Shared on May 20, 2010 at 11:43 pm By:
Treatment With Rituxan May Reduce Recurrence of Follicular Lymphoma: http://bit.ly/cb69n8
Roche's Rituxan halves risk of lymphoma recurrence | Reuters
reuters.com — “LOS ANGELES (Reuters) - Continued use of Rituxan, a drug sold by Roche Holding AG and Biogen Idec Inc, reduced by about 50 percent the chance that follicular lymphoma patients would have their cancer return,” View full resource at reuters.com
Most Recently Shared on May 20, 2010 at 6:08 pm By:
Roche's Rituxan halves risk of lymphoma recurrence: LOS ANGELES (Reuters) - Continued use of Rituxan,... http://bit.ly/9O2Lgz #health #news
Roche's Rituxan halves risk of lymphoma recurrence | Reuters
reuters.com — “LOS ANGELES (Reuters) - Continued use of Rituxan, a drug sold by Roche Holding AG and Biogen Idec Inc, reduced by about 50 percent the chance that follicular lymphoma patients would have their cancer return,” View full resource at reuters.com
Most Recently Shared on May 20, 2010 at 6:06 pm By:
Roche's Rituxan halves risk of lymphoma recurrence http://link.reuters.com/gux45k
Roche's Rituxan halves risk of lymphoma recurrence | Reuters
reuters.com — “LOS ANGELES (Reuters) - Continued use of Rituxan cut by about 50 percent the risk that follicular lymphoma patients would have their cancer return, according to a late-stage study of the drug, which is” View full resource at reuters.com
Most Recently Shared on May 21, 2010 at 1:15 am By:
Hisham Rana, MD Doctor and Physician
Study: Roche's Rituxan halves risk of follicular lymphoma recurrence http://bit.ly/c6iFyw - #health #pharma
FDA Approves Rituxan To Treat Two Rare Disorders
medicalnewstoday.com — “The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener's granulomatosis (WG) and microscopic polya” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2011 at 8:05 am By:
MNT Drug Approvals Health News
FDA Approves Rituxan To Treat Two Rare Disorders http://mnt.to/3TRb #regulatory
FDA Weighs the Risks of Rituxan - WSJ.com
online.wsj.com — “The FDA is discussing whether patients on cancer drug Rituxan should use it for a shorter period or take breaks, in light of reports of a link to a usually fatal brain disease.” View full resource at online.wsj.com
Most Recently Shared on June 1, 2009 at 12:52 am By:
FDA Weighs the Risks of Rituxan http://tinyurl.com/nexw2d
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Barbara J. Martin
Neurologist emeritus, Pathophilia blogger, noir lover
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
Advertisement
